跳至主要内容
临床试验/EUCTR2019-004599-20-FR
EUCTR2019-004599-20-FR招募中1 期

Effects of early testosterone gel administration on physical performance in the critically ill: a randomised double blind clinical trial - TestICUs

CHU DE CLERMONT-FERRAND0 个研究点目标入组 600 人开始时间: 2021年5月25日最近更新:
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Males and females aged over 18 years
  • COVID-19 or not
  • Invasive mechanical ventilation expected to be required for more than 48 hours
  • Written informed consent obtained from the patient or the legal representative
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 400
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 200

排除标准

  • History of prostate cancer
  • History of breast cancer
  • PSA = 4 ng/ml
  • ICU length of stay > 120 h before enrollment
  • Pre-existing illness with a life expectancy of <6 months
  • Recent intracranial or spinal cord injury (< 1 month)
  • Recent hemorrhagic or ischemic stroke( < 1 month)
  • Neuromuscular disease
  • Cardiac arrest in non-shockable rhythm
  • Pre-existing cognitive impairment or language barrier
  • Inability to walk without assistance prior to acute ICU illness (use of a cane or walkers not excluded)
  • Documented allergy to testosterone
  • Age > 80 years
  • Breast feeding
  • Patients under legal guardianship

研究者

发起方
CHU DE CLERMONT-FERRAND

相似试验